NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Effectiveness Evaluation of a Mobile Application for Rheumatoid Arthritis

CompletedNA

Sponsor: Kırıkkale University

Conditions: Rheumatoid Arthritis, Mobile Application

Interventions: mobile app, Control (Standard treatment)

Countries: Turkey (Türkiye)

The aim of this experimental study is to develop a mobile application for patients with rheumatoid arthritis based on evidence-based recommendations and to evaluate the effectiveness of the developed application. Research Questions 1. Is the mobile application developed for patients with rheumatoid arthritis effective in improving their quality of life? 2. Is the mobile application developed for patients with rheumatoid arthritis effective in reducing their disease activity? The researchers will enable the intervention group to use the mobile application in order to assess its effectiveness, while the control group will receive routine care throughout the study period. Participants in the intervention group will use the mobile application for 12 weeks. Changes in the parameters determined by the researchers will be examined before and after the usage period. Patients in the control group will be evaluated after the initial consultation and at the end of 12 weeks. At the conclusion of the study, the control group will also be provided access to the mobile application.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Be 18 years of age or older
* Diagnosis of Rheumatoid Arthritis according to the American College of Rheumatology (ACR) 1987 criteria
* Receiving stable treatment for the last 3 months with no new treatments added at the last check-up
* Ability to read and write in Turkish
* Ownership of a personal smartphone with internet connectivity and the ability to use an application
* Willingness to participate in the study

Exclusion Criteria:

* Pregnancy or breastfeeding
* Having a diagnosis of inflammatory diseases or a disease that may significantly affect the functional status (such as Multiple Sclerosis, stroke, Systemic Lupus Erythematosus, Ankylosing Spondylitis, Psoriatic Arthritis)
* Not having any neurological or psychiatric disease/problem diagnosed by a physician
* Wanting to withdraw from the study
* Exiting during the study process
* Not logging in to the mobile application once a week during the study implementation period (twelve weeks) for the intervention group

Locations (2)

Ankara, Yahşihan, Turkey (Türkiye)
Ankara, Turkey (Türkiye)